Home » Topics » BioWorld Science

BioWorld Science
RSS

Hedgehog pathway modulators patented by Development Center for Biotechnology, DCB-USA

June 19, 2018

Xavier University of Louisiana divulges androgen receptor signaling inhibitors

June 19, 2018

Wellcome Trust grant supports Karuna's development of KarXT for schizophrenia

June 19, 2018

XMT-1522 demonstrates safety and preliminary efficacy in phase I study

June 19, 2018

Roche and Foundation Medicine enter definitive merger agreement

June 19, 2018

FDA removes clinical hold on IGNITE DMD study of SGT-001

June 19, 2018

Sanofi completes acquisition of Ablynx

June 19, 2018

Clover initiates phase I trial of SCB-313 for malignant ascites

June 19, 2018

Cognition Therapeutics initiates SPARC trial of Elayta in Alzheimer's disease

June 19, 2018

MXRA8, a drug-targetable receptor for chikunguya and other arthritogenic alphaviruses

June 19, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 4, 2026.
University of Western Australia patents 5-HT2A/B modulators
BioWorld Science
University of Western Australia has identified new lysergic acid diethylamide (LSD) analogues acting as 5-HT2A and 5-HT2B modulators reported to be useful for the...
Alceptor Therapeutics discovers new α2B-adrenoceptor agonists
BioWorld Science
Alceptor Therapeutics Inc. has patented new pyrazol-5-amine α2B-adrenoceptor agonists reported to be useful for the treatment of pain and hypertension.
EQ-504 is AhR agonist for ulcerative colitis, related disorders
BioWorld Science
Activating the aryl hydrocarbon receptor (AhR) in immune cells enhances anti-inflammatory pathways and limits pathogenic immune responses. Equillium Inc. has...
Quintuple GLP-1–GIP–PPAR agonist for obesity and diabetes control
BioWorld
A new molecule combines the action of two incretins, GLP-1 and GIP, hormones that regulate glucose and appetite, with lanifibranor, a triple agonist of peroxisome...